What is it?
What glutathione is
1Glutathione is a tripeptide found in the body and commonly sold as reduced glutathione (GSH). Product listings also use form terms such as liposomal glutathione; those forms should be compared as separate evidence contexts.
One four-week trial found no significant biomarker change
3In a four-week double-blind study in 40 healthy adults, 500 mg twice daily did not significantly change oxidative-stress or glutathione-status measures. This null finding reinforces why oral forms should not be assumed interchangeable.
Names, aliases and forms
Mechanisms of action
Cellular redox role
1Glutathione is a thiol-containing tripeptide involved in cellular redox processes. That biochemical role alone does not predict a practical supplement outcome.
Oral availability has varied by study design
2An older study in healthy volunteers found that one 3 g oral dose did not raise circulating glutathione to a clinically meaningful extent. Single-dose findings should not be equated with later repeated-dose biomarker studies.
Specialty oral forms need separate evidence
5A four-week liposomal trial measured changes in body stores and selected markers. Its findings apply to the studied liposomal preparation, not automatically to powders or standard capsules.
Potential effects and evidence map
Oral glutathione human studies are small and form-specific. A four-week 1 g/day trial found no significant change in oxidative-stress or glutathione-status measures, while a six-month trial at 250 or 1000 mg/day reported higher blood glutathione measures and a liposomal study reported changes in body stores and selected markers. These findings do not establish direct cognitive outcomes.
Repeated oral studies have measured glutathione-related biomarkers, but they do not establish direct brain-performance benefits.
Typical dosages and timing
A double-blind trial used these two daily oral doses to assess glutathione body stores. This is research exposure, not a personal regimen.
Timing & effect horizon
The cited studies assessed repeated intake over four weeks or six months. These are research windows, not validated same-day onset, duration, or cycle guidance.
Safety, side effects and risk profile
Small, form-specific biomarker studies do not establish broader outcomes or long-term safety.
The four-week liposomal study recorded only minor adverse events that were not attributed to either treatment group. This is not a general tolerability finding for every form or exposure.
Legal and regulatory status
In the United States, FDA does not approve dietary supplements for safety or effectiveness before marketing. Product listings do not validate effectiveness, and marketing claims must be truthful and nonmisleading under the applicable U.S. rules.
Practical buying and quality notes
- Match reduced GSH, liposomal products, powders, capsules, and solutions before price comparisons. For solutions, compare the labelled amount per serving and volume; for powders or capsules, compare like-for-like grams or capsules. A lower cross-form price is not a universal best price.5
FAQ
Is glutathione a nootropic?
4The cited human studies primarily measured biomarkers rather than cognitive performance. Glutathione is not supported here as a reliable direct focus or memory supplement.
What dose did human studies use?
4One six-month randomized trial used 250 or 1000 mg per day in healthy nonsmokers. That is a research context, not an individual use protocol.
Is liposomal glutathione different?
5A small four-week liposomal study reported changes in body stores and selected markers. Its results should not be generalized to every reduced glutathione product.
How long did the cited studies last?
4The cited repeated-intake studies lasted four weeks or six months. That does not establish an effect duration or cycling schedule.
What should buyers compare?
5Check the labelled glutathione form, amount per serving, route, and like-for-like unit price. Avoid assuming that a product form has the same evidence as a different preparation.
References
- PubChem Compound Summary for Glutathione. National Center for Biotechnology Information.
- Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992;43(6):667-669.
- Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827-833.
- Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263.
- Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018;72(1):105-111.
- U.S. Food and Drug Administration. Dietary Supplements.